HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hensin Tsao Selected Research
Hensin Tsao Research Topics
Disease
53
Melanoma (Melanoma, Malignant)
12/2021 - 06/2002
31
Neoplasms (Cancer)
01/2021 - 11/2003
4
Skin Neoplasms (Skin Cancer)
10/2021 - 11/2004
3
Neoplasm Metastasis (Metastasis)
01/2019 - 03/2015
2
Uveal melanoma
11/2019 - 10/2006
2
Colonic Neoplasms (Colon Cancer)
01/2019 - 07/2015
2
Cutaneous Malignant Melanoma
01/2019 - 10/2006
2
Skin Diseases (Skin Disease)
07/2013 - 11/2008
2
Nevus (Nevi)
03/2013 - 12/2009
2
Carcinogenesis
03/2012 - 04/2010
1
COVID-19
01/2021
1
Keloid
11/2020
1
Hypoxia (Hypoxemia)
11/2020
1
Exanthema (Rash)
10/2019
1
Blister (Bulla)
10/2019
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2019
1
Margins of Excision
01/2019
1
Breast Neoplasms (Breast Cancer)
01/2019
1
Hemangioma (Angioma)
01/2019
1
Hutchinson's Melanotic Freckle (Lentigo Maligna)
01/2019
1
Amelanotic Melanoma (Amelanotic Melanomas)
11/2016
1
Dysplastic Nevus Syndrome (Dysplastic Nevus)
10/2016
1
Pigmented Nevus (Melanocytic Nevus)
11/2015
1
Blue Nevus
11/2015
1
Parkinson Disease (Parkinson's Disease)
03/2013
1
Telangiectasis (Telangiectasia)
11/2009
1
Retinoblastoma (Glioblastoma, Retinal)
01/2009
1
Psoriasis (Pustulosis Palmaris et Plantaris)
11/2008
Drug/Important Bio-Agent (IBA)
13
Proteins (Proteins, Gene)
FDA Link
11/2020 - 12/2005
8
Biological Products
IBA
12/2021 - 11/2004
6
Vemurafenib
IBA
01/2021 - 01/2012
6
Phosphotransferases (Kinase)
IBA
01/2021 - 12/2007
4
Pharmaceutical Preparations
IBA
01/2021 - 12/2007
4
Cyclin-Dependent Kinase Inhibitor p16
IBA
01/2016 - 01/2009
3
Microphthalmia-Associated Transcription Factor
IBA
01/2019 - 11/2011
3
Mitogen-Activated Protein Kinases
IBA
02/2012 - 04/2006
3
Tumor Suppressor Protein p14ARF (p14ARF)
IBA
01/2009 - 12/2005
2
RNA (Ribonucleic Acid)
IBA
01/2021 - 08/2012
2
Collagen
IBA
11/2020 - 12/2009
2
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
01/2020 - 10/2016
2
Telomerase (Telomerase Reverse Transcriptase)
IBA
01/2020 - 01/2017
2
DNA (Deoxyribonucleic Acid)
IBA
01/2019 - 01/2009
2
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
07/2015 - 02/2012
2
Survivin
IBA
04/2015 - 08/2013
2
Dacarbazine (DIC)
FDA Link
Generic
03/2015 - 06/2014
2
Mitogens
IBA
06/2014 - 12/2007
2
nutlin 3
IBA
08/2013 - 02/2012
2
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
02/2012 - 07/2010
2
Antigens
IBA
07/2010 - 06/2002
1
dabrafenib
IBA
01/2021
1
Protein Kinases (Protein Kinase)
IBA
01/2021
1
tyrosine receptor (receptor, tyrosine)
IBA
01/2021
1
Dasatinib (BMS 354825)
FDA Link
07/2020
1
nilotinib
FDA Link
07/2020
1
Sunitinib (Sutent)
FDA Link
07/2020
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
07/2020
1
Cytokines
IBA
07/2020
1
Imatinib Mesylate (Gleevec)
FDA Link
07/2020
1
Calcium Channels (Calcium Channel)
IBA
11/2019
1
Nivolumab
IBA
10/2019
1
Imiquimod (Aldara)
FDA Link
Generic
01/2019
1
Adenosine Triphosphate (ATP)
IBA
01/2019
1
Carcinogens
IBA
01/2019
1
Formaldehyde (Formol)
FDA Link
01/2019
1
Paraffin
IBA
01/2019
1
RNA Helicases (RNA Helicase)
IBA
01/2019
1
DEAD-box RNA Helicases
IBA
01/2019
1
Desmin
IBA
05/2018
1
Calbindin 2
IBA
05/2018
1
Oral Contraceptives
IBA
03/2017
1
Estrogens (Estrogen)
FDA Link
03/2017
1
pheomelanin
IBA
11/2016
1
Tensins
IBA
01/2016
1
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
01/2016
1
Cyclin D
IBA
01/2016
1
Apoptosis Regulatory Proteins
IBA
04/2015
1
Ligands
IBA
03/2015
1
Protons (Proton)
IBA
09/2014
1
Alkylating Agents
IBA
06/2014
1
Interleukin-2 (IL2)
IBA
06/2014
1
Immunologic Adjuvants (Immunologic Adjuvant)
IBA
06/2014
1
eumelanin
IBA
01/2014
1
Hormones (Hormone)
IBA
03/2013
1
Melanins (Melanin)
IBA
06/2012
1
Transcription Factors (Transcription Factor)
IBA
11/2011
1
Doxorubicin (Adriamycin)
FDA Link
Generic
11/2011
1
Cyclin-Dependent Kinase 4
IBA
02/2011
1
MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)
IBA
07/2010
1
Transforming Growth Factor beta (TGF-beta)
IBA
11/2009
1
Type 1 Melanocortin Receptor
IBA
01/2009
Therapy/Procedure
23
Therapeutics
07/2021 - 04/2005
4
Immunotherapy
01/2019 - 07/2010
2
Radiotherapy
01/2019 - 09/2014
1
Treatment Delay
10/2021
1
Mohs Surgery (Mohs' Micrographic Surgery)
01/2019
1
Hormone Replacement Therapy (Therapy, Hormone Replacement)
03/2017
1
Molecular Targeted Therapy
05/2015
1
Drug Therapy (Chemotherapy)
11/2011
1
Ambulatory Care (Outpatient Care)
06/2011
1
Precision Medicine
12/2010